Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mind Medicine (MindMed) Inc. - Common Shares
(NQ:
MNMD
)
15.02
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mind Medicine (MindMed) Inc. - Common Shares
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
34
35
Next >
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
↗
March 14, 2023
Via
Benzinga
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
↗
March 13, 2023
Via
Benzinga
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
↗
March 13, 2023
Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial
Via
Benzinga
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
↗
March 13, 2023
The Benzinga Psychedelics Capital Conference (PCC) is rapidly becoming the place to be for all those interested or involved in the space. In addition to being the place where deals are done, you'll...
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
↗
March 10, 2023
Via
Benzinga
MindMed Reports Full-Year 2022 Financial Results, Highlighting Anxiety & Autism Studies
↗
March 10, 2023
Clinical-stage biopharma company Mind Medicine (MindMed), Inc. (NASDAQ: MNMD) shared its financial results for the full year ended Dec. 31, 2022. Numbers show solid stability:
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 9, 2023
↗
March 09, 2023
Via
Benzinga
MindMed Reports Full Year 2022 Financial Results and Business Highlights
March 09, 2023
From
MindMed
Via
Business Wire
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
March 08, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
↗
March 07, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 6, 2023
↗
March 06, 2023
Via
Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
↗
March 06, 2023
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.
Via
Benzinga
The 5 Cannabis Category Performances Have Ranged From +14.5% To -2.7% YTD
↗
March 04, 2023
The 5 categories in the cannabis sector perform quite differently from each other.
Via
Talk Markets
Cybin, GH Research Among Top Psychedelic Movers Of Today
↗
March 03, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 2, 2023
↗
March 02, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
↗
March 01, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2023
↗
February 28, 2023
Via
Benzinga
MindMed to Participate in March Investor Conferences
February 28, 2023
From
MindMed
Via
Business Wire
Psychedelic Stock Gainers And Losers From February 27, 2023
↗
February 27, 2023
Via
Benzinga
"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio By 2-To-1 Margin YTD
↗
February 26, 2023
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but perhaps some will bounce back with
Via
Talk Markets
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD
↗
February 26, 2023
The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage...
Via
Talk Markets
Only 2 Of 5 Cannabis Categories Have Advanced YTD
↗
February 25, 2023
The 5 categories in the cannabis sector perform quite differently from each other but YTD the common trend is mostly downward.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From February 24, 2023
↗
February 24, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 23, 2023
↗
February 23, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2023
↗
February 22, 2023
Via
Benzinga
Why Wag! Group Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
↗
February 22, 2023
Gainers
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 21, 2023
↗
February 21, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 20, 2023
↗
February 20, 2023
Via
Benzinga
"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio YTD By A 2-To-1 Margin
↗
February 19, 2023
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. Perhaps some will bounce back with
Via
Talk Markets
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD
↗
February 17, 2023
A look at the performance of the six largest psychedelic stocks by market capitalization.
Via
Talk Markets
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
34
35
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
